BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lesmana CRA. Impact of endoscopic ultrasound-guided radiofrequency ablation in managing pancreatic malignancy. World J Gastrointest Surg 2023; 15(2): 163-168 [PMID: 36896311 DOI: 10.4240/wjgs.v15.i2.163]
URL: https://www.wjgnet.com/2307-8960/full/v15/i2/163.htm
Number Citing Articles
1
Joan B. Gornals. EUS-guided radiofrequency ablation in pancreatic cancer: Promising but still questionable!Gastrointestinal Endoscopy 2024; 100(2): 259 doi: 10.1016/j.gie.2024.04.022
2
Kerui Pan, Sisi Wang, Xueping Li, Shuoming Wu, Ashraf Elbahrawy. Efficacy and safety of ultrasound-guided radiofrequency ablation combined with transhepatic artery embolization chemotherapy for hepatocellular carcinoma: A meta-analysisPLOS ONE 2024; 19(9): e0305965 doi: 10.1371/journal.pone.0305965
3
Alejandra Vargas, Priyata Dutta, Eileen S. Carpenter, Jorge D. Machicado. Endoscopic Ultrasound-Guided Ablation of Premalignant Pancreatic Cysts and Pancreatic CancerDiagnostics 2024; 14(5): 564 doi: 10.3390/diagnostics14050564
4
Hironari KATO, Kazuyuki MATSUMOTO. Current status of endoscopic ultrasound (EUS)-guided ablation therapy for pancreatic neuroendocrine neoplasms (PNENs)Suizo 2023; 38(4): 229 doi: 10.2958/suizo.38.229
5
Cosmas Rinaldi Adithya Lesmana. Endoscopic loco-regional treatment in controlling pancreatic neuroendocrine tumors (PNETs) behavior: a case series and literature reviewClinical Journal of Gastroenterology 2024; 17(4): 754 doi: 10.1007/s12328-024-01959-2